
world
Immunotherapy bowel cancer drug works for 100% of patients â researchers
Jemperli (also called dostarlimab) from GSK showed âunprecedented resultsâ, the firm said, with no evidence of disease in all patients treated
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC